01 August 2016 EMA/262750/2016 Stakeholders and Communication Division

Agenda - Developing a framework of collaboration between EMA and academia A workshop of the Healthcare Professionals Organisations Working Party (HCPWP) 15 June 2016, 11:00hrs to 16:30hrs – meeting room: 3E

Background In view of the growing complexity with which new medicines are being developed, evaluated and monitored it has become indispensable that academia and regulators develop a partnership that will foster a proactive process to support innovation and channel it into the continuous evolution of regulatory science. The EU Medicines Agencies Network Strategy to 20201 highlights the importance of developing a sound collaboration between the EU Regulatory Network and the academic world in order to keep abreast of the advances in science to ensure that innovative medicinal products can be optimally developed for the benefit of all European citizens. As a consequence, the Agency has started an internal reflection and an external consultation process with the objective of informing the development of a framework of collaboration with academia. During its June meeting, the HCPWP is hosting a workshop that represents the culmination of the consultation process that will allow for the definition of a framework of collaboration based on robust foundations.

Objectives 1. Collectively review the status quo 2. Present the different perspectives and expectations 3. Discuss the main pillars of the framework

1

European Union Medicines Agencies Network Strategy to 2020 - Working together to improve health

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Chair: I. Moulon (EMA) 15 June 2016 10:45

Registration

11:00

Welcome (Health and safety information; Interests disclosure)

Speaker

I. Moulon (EMA)

Introduction, background, and objectives of the workshop 11:05

Opening remarks

G. Rasi (EMA)

1. Building the foundations 11:15

1.1 Partnership with academia: today and tomorrow

M. Papaluca (EMA)

11:25

1.2 Academia consultation: the survey results

M. Ensini (EMA)

11:40

1.3 The challenges of personalised medicine: contribution from the EU Research Infrastructures

J-E. Litton (BBMRI-ERIC)

11:55

1.4 The system and academic impact

H. Linden (EUFEPS)

12:10

1.5 Open discussion

Facilitators: I. Moulon (EMA) / G. Calvo (HCPWP)

13:15

Lunch

2. The main pillars of the framework 14:00

2.1 HCPWP Academia Topic Group proposals

R. Giuliani (HCPWP)

14:15

2.2 Capitalising on the EU Network Training Centre for capacity

Z. Frias (EMA)

and capability building in the EU network 14:30 14:50 15:10

2.3 EMA support and involvement into regulatory science

C. de Vries (EMA)

Coffee break 2.4 Open discussion

Facilitators: S. Bonini (EMA) / R. Giuliani (HCPWP)

16:10

2.5 The outline of the EMA framework of collaboration with

I. Moulon (EMA)

academia 16:25

2.6 Conclusions

I. Moulon (EMA) / G. Calvo (HCPWP)

16:30

End of meeting

Agenda - Developing a framework of collaboration between EMA and academia EMA/262750/2016

Page 2/2

Agenda - European Medicines Agency - Europa EU

Aug 1, 2016 - 15 June 2016, 11:00hrs to 16:30hrs – meeting room: 3E ... hosting a workshop that represents the culmination of the consultation process that ...

118KB Sizes 1 Downloads 252 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Nov 3, 2016 - Scope: 'Optimising the development of ATMPs to meet patient needs' ... the CAT would like to discuss with company representatives in person.

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - under Article 107i of Directive 2001/83/EC, based on pharmacovigilance data. Action: For adoption of ..... manufacturing process; and 3) removal of the following missing information: special patient groups. Action: For .... analysis of

Agenda - European Medicines Agency - Europa EU
4 days ago - Meningococcal group A, C, W135 and Y conjugate vaccine - NIMENRIX (CAP) -. EMEA/H/C/002226/II/0078 . ...... Applicant: AstraZeneca AB.

Agenda - European Medicines Agency - Europa EU
Jul 31, 2017 - Human Medicines Research and Development Support Division. Agenda ... use of such prior knowledge in regulatory application dossiers, to support manufacturing and control strategies ... of accelerated access schemes.

Agenda - European Medicines Agency - Europa EU
Oct 26, 2016 - (as Web sites for social networking and microblogging) through which ... 09:10. Opening remarks. D. Haerry (PCWP)/. G. Calvo (HCPWP). 1.

Agenda - European Medicines Agency - Europa EU
Nov 27, 2017 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be